Skip to Content

T. Rowe Price Health Sciences PRHSX

Analyst rating as of
NAV / 1-Day Return
92.42  /  0.48 %
Total Assets
16.5 Bil
Adj. Expense Ratio
0.750%
Expense Ratio
0.750%
Fee Level
Low
Longest Manager Tenure
6.66 years
Category
Health
Investment Style
Large Growth
Min. Initial Investment
2,500
Status
Open
TTM Yield
0.00%
Turnover
34%

Morningstar’s Fund Analysis PRHSX

Will PRHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Offers an edge in the healthcare sector.

Senior Analyst

Summary

|

T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.

Unlock our full analysis with Morningstar Investor